$3.940
-0.069 (-1.75%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
CNS Pharmaceuticals Inc (CNSP) Moving Averages Convergence Divergence (MACD) indicator is -0.28, suggesting CNSP is Strong sell.
CNS Pharmaceuticals Inc (CNSP) 20-Day simple moving average is 4.75, while CNS Pharmaceuticals Inc (CNSP) share price is $—, making it Sell.
CNS Pharmaceuticals Inc (CNSP) 60-Day simple moving average is 5.26, while CNS Pharmaceuticals Inc (CNSP) share price is $—, making it Sell.
Technical Analysis for CNSP
AI Technical CNSPAs of 2026-11-07, the technical board for CNS Pharmaceuticals Inc (CNSP) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $3.94 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 36.052, MACD stands at -0.276 (Sell), Stochastic %K stands at 23.596, Stochastic %D stands at 33.833 and CCI stands at -175.514 (Buy).
CNSP trades below the 60-day SMA (5.26) and below the 200-day SMA (4.52). Immediate resistance sits at Classic R1 5.35, then R2 6.18. Support sits at Classic S1 3.79, then S2 3.06.
CNS Pharmaceuticals Inc (CNSP) Support & Resistance Level
CNS Pharmaceuticals Inc (CNSP) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 36.052 |
| STOCHk_14_3_3 | 23.596 |
| STOCHd_14_3_3 | 33.833 |
| CCI_20 | -175.514 |
| AO_5_34 | -0.627 |
| MOM_10 | -1.050 |
| MACD_12_26_9 | -0.276 |
CNS Pharmaceuticals Inc (CNSP) Relative Strength Index (RSI_14) is 36.052, creating a Neutral signal.
CNS Pharmaceuticals Inc (CNSP) Stochastic %K is 23.596, creating a Neutral signal.
CNS Pharmaceuticals Inc (CNSP) Stochastic %D is 33.833, creating a Neutral signal.
CNS Pharmaceuticals Inc (CNSP) CCI_20 is -175.514, creating a Buy signal.
CNS Pharmaceuticals Inc (CNSP) Awesome Oscillator (AO) is -0.627, creating a Sell signal.
CNS Pharmaceuticals Inc (CNSP) Momentum (MOM) is -1.050, creating a Sell signal.
CNS Pharmaceuticals Inc (CNSP) Moving Average Convergence Divergence (MACD) is -0.276, creating a Sell signal.
CNS Pharmaceuticals Inc (CNSP) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 4.242 | Sell |
| MA_10 | 4.520 | Sell |
| MA_20 | 4.749 | Sell |
| MA_60 | 5.265 | Sell |
| MA_200 | 4.520 | Sell |
| MA_250 | 4.921 | Sell |
CNS Pharmaceuticals Inc (CNSP) 5-Day simple moving average is 4.242, while CNS Pharmaceuticals Inc (CNSP) share price is $, making it a Sell.
CNS Pharmaceuticals Inc (CNSP) 10-Day simple moving average is 4.520, while CNS Pharmaceuticals Inc (CNSP) share price is $, making it a Sell.
CNS Pharmaceuticals Inc (CNSP) 20-Day simple moving average is 4.749, while CNS Pharmaceuticals Inc (CNSP) share price is $, making it a Sell.
CNS Pharmaceuticals Inc (CNSP) 60-Day simple moving average is 5.265, while CNS Pharmaceuticals Inc (CNSP) share price is $, making it a Sell.
CNS Pharmaceuticals Inc (CNSP) 200-Day simple moving average is 4.520, while CNS Pharmaceuticals Inc (CNSP) share price is $, making it a Sell.
CNS Pharmaceuticals Inc (CNSP) 250-Day simple moving average is 4.921, while CNS Pharmaceuticals Inc (CNSP) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.